Anti-platelet or anti-coagulant agent for prevention of ischemic stroke in patients with end-stage renal disease and atrial fibrillation, is it necessary?

Jien Jiun Chen, Lian Yu Lin, Yao Hsu Yang, Juey Jen Hwang, Pau Chung Chen*, Jiunn Lee Lin

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

1 Scopus citations
Original languageEnglish
Pages (from-to)53
Number of pages1
JournalInternational Journal of Cardiology
StatePublished - 23 07 2015
Externally publishedYes


  • Aspirin stroke
  • Atrial fibrillation
  • Coumadin
  • End-stage renal disease

Cite this